Seacoast Capital Invests $30M in SkinCure Oncology
September 24, 2019
Seacoast Capital announced a $30 million syndicated growth equity investment in SkinCure Oncology, a Burr Ridge, Illinois-based provider of turnkey image-guided superficial radiation therapy (IG-SRT) services for dermatologists. The non-control capital infusion was used to facilitate a shareholder dividend and to capitalize SkinCure for future growth and national expansion.
- Buyers
- Seacoast Capital
- Targets
- SkinCure Oncology
- Industry
- Healthcare Services
- Location
- Illinois, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
H.I.G. Capital Acquires SkinCure Oncology
October 1, 2024
Healthcare Services
H.I.G. Capital, through an affiliate, completed the acquisition of SkinCure Oncology Intermediate LLC, a Burr Ridge, Illinois–headquartered provider of image-guided superficial radiation therapy (IG-SRT) for nonmelanoma skin cancer. SkinCure's executive team, led by CEO Kerwin Brandt, will remain in place and significant shareholders; Marathon Asset Management provided a senior-secured credit facility to finance the transaction. The investment aims to support expansion of the GentleCure platform across existing and new dermatology and Mohs practice partners nationwide.
-
Pine Tree Equity Invests in Suncoast Skin Solutions
May 1, 2021
Healthcare Services
Pine Tree Equity IV, LP made a growth equity investment in Suncoast Skin Solutions in May 2021. The capital will support expansion of facility and physician capacity at the Lutz, Florida-based medical dermatology practice, which operates 19 Suncoast-branded offices and will remain under the operating control of founders Dr. Chris and Rebecca Ewanowski.
-
Seacoast Capital Invests in Focus Technology Solutions (Majority Recapitalization)
November 29, 2023
IT Services
Seacoast Capital has made its first investment from Seacoast Capital Partners V by providing equity and debt to support a majority recapitalization of Focus Technology Solutions alongside the company's management team. The financing enables a management-led recapitalization, promotes Chris Caprio to CEO, and provides working capital to support Focus's growth in managed IT, cloud and cybersecurity services.
-
Seneca Partners Invests £1.2m in SolasCure
August 18, 2021
Biotechnology
Seneca Partners has invested £1.2 million into Cambridge-based biotech start-up SolasCure to support development of its wound‑care product Aurase. The funding (via Seneca EIS Portfolio Service and Seneca Growth Capital VCT) will help SolasCure progress Aurase into clinical trial stages.
-
DermCare Management Acquires Four Dermatology Practices
February 22, 2022
Healthcare Services
DermCare Management, a portfolio company of Hildred Capital Management, announced partnerships to bring Stone Oak Dermatology, Irradiance Medical Group, Altman Dermatology, and Icecreamwala Dermatology into its platform. The add-on deals expand DermCare’s footprint across Florida, Texas and California, increasing the platform to 46 locations and roughly 100 medical providers.
-
Gauge Capital Makes Strategic Investment in East Coast Institute for Research
November 27, 2023
Healthcare Services
Gauge Capital has made a strategic investment in East Coast Institute for Research (ECIR), providing growth capital and recapitalizing the company to support expansion and infrastructure investment. ECIR, a Jacksonville, Florida–based clinical research site organization with eight sites across northern Florida and Georgia, will retain its management team while Gauge partners on the board to help accelerate growth and expand access to clinical research.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.